International Journal of Preventive Medicine

BRIEF COMMUNICATION
Year
: 2020  |  Volume : 11  |  Issue : 1  |  Page : 76-

Hypothesis of COVID-19 therapy with sildenafil


Limodio Mario1, Menicagli Roberto2, Limodio Marta3, Casotti Maria Teresa4, Menicagli Laura5 
1 Researcher, UOC, Infectious and Tropical Diseases, Spaziani Hospital, Frosinone, Italy
2 Biochemistry Senior Scientist Consultant, University Milan, Italy
3 Pharmacological Researcher, ASST, Frosinone, Italy
4 Department of Radiodiagnostic, Pisa University, Italy
5 Department of Radiodiagnostic, Policliclinico San Donato, Milan University, Italy

Correspondence Address:
Menicagli Roberto
20060 Mediglia
Italy

Backgound: Bacterial or viral infections often cause acute and severe systemic inflammation, which affects the lungs lipopolysaccharide (LPS), a pathogenic component of the membrane of gram-negative bacteria, stimulates active innate immune cells, monocytes, macrophages to produce inducible nitric oxide synthase (iNOS). Excess production of this compound occurs in COVID-19 resulting in inflammatory cascade and thromboembolism. We intend to propose the use of sildenafil to reduce this production. Method: The analysis of biochemical pathways shows that viral infection produces a high amount of nitric oxide (NO), with an acute inflammatory process. Results: In the case of COVID-19 infection we verified that numerous biochemical processes activate a cascade of inflammatory processes through the activation of iNOS with uncontrolled generation of (NO). Conclusions: iNOS is the cause of damage to host cells with a consequent pulmonary thromboembolic lung phenomenon in a contest of interstitial pneumonia. This study proposes the use of sildenafil to counter the inflammatory cascade and thromboembolic episodes.


How to cite this article:
Mario L, Roberto M, Marta L, Teresa CM, Laura M. Hypothesis of COVID-19 therapy with sildenafil.Int J Prev Med 2020;11:76-76


How to cite this URL:
Mario L, Roberto M, Marta L, Teresa CM, Laura M. Hypothesis of COVID-19 therapy with sildenafil. Int J Prev Med [serial online] 2020 [cited 2020 Oct 1 ];11:76-76
Available from: http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2020;volume=11;issue=1;spage=76;epage=76;aulast=Mario;type=0